Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Addiction Science & Clinical Practice January 19, 2020 Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo et al.
Abstract Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a high-risk patient with a history of failed initiations due, in part, to withdrawal symptoms. Using an assertive outreach model and a...